logo
Hinckley: Community diagnostic centre on track for opening

Hinckley: Community diagnostic centre on track for opening

BBC News22-02-2025

A new diagnostics hub is on track to open in May, according to an NHS body.The Leicester, Leicestershire and Rutland Integrated Care Board (LLR ICB) said the £24.6m facility would provide about 89,000 diagnostic tests per year in Hinckley.These tests will include CT and MRI scans, endoscopy, X-ray and ultrasounds, delivered by the University Hospitals of Leicester (UHL) NHS Trust.Construction on the site has been under way since April 2024 at Hinckley and District Community Hospital.
The LLR ICB said "significant progress has been made" over recent weeks, despite a January break-in at the site, for which four men were arrested.Helen Hendley, director of planned care for the LLR ICB, said: "We've made great progress on the new facility, which will make a big difference to local people when it opens. It will help to reduce waiting times and provide a more convenient facility for people in the community."Providing services closer to people's homes and where they work improves access to health services. We're excited to see the positive difference this facility will make."The other hub in the county - at Leicester General Hospital - has been running since 2021.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tesco shoppers warned after supermarket puts new label on popular product
Tesco shoppers warned after supermarket puts new label on popular product

Daily Mirror

timean hour ago

  • Daily Mirror

Tesco shoppers warned after supermarket puts new label on popular product

The NHS has issued a stark warning to Tesco shoppers who buy the supermarket's own-brand toilet roll, urging them to 'keep an eye out' and 'contact your GP practice if something doesn't feel right' The NHS is calling on Tesco customers to 'keep an eye out' and to 'contact your GP practice if something doesn't feel right', issuing a stark health warning as Tesco's exclusive Luxury Soft loo rolls now sport the NHS logo on their wrapping. In a bid to ramp up bowel cancer awareness, the partnership between NHS and Britain's leading grocer aims to tap into the regular shopping habits of consumers. Echoing across social media platform X, the NHS broadcasted: "Keep an eye out for our logo on @Tesco toilet roll-78.9 million rolls sold and counting!" The move acts as a timely nudge for shoppers to stay vigilant for early signs of cancer during their bathroom routine. ‌ READ MORE: 'I'm a fashion editor and found an unlikely retailer selling glitzy festival-ready outfits' The NHS is highlighting: "It's a reminder for people to look out for possible signs of cancer when going to the loo. Know what's normal for you and contact your GP practice if something doesn't feel right." ‌ On each pack, just below the NHS logo, is a critical message which reads: "Finding cancer earlier makes it more treatable and can save lives." On this unique packaging, customers will find a checklist of cancer indicators that might be detected in the loo, including changes in bowel movements or blood traces, reports the Express. For an exhaustive list of cancer symptoms, individuals are encouraged to navigate to Signs of bowel cancer include: changes in your poo, such as having softer poo, diarrhoea or constipation that is not usual for you needing to poo more or less often than usual for you blood in your poo, which may look red or black bleeding from your bottom often feeling like you need to poo, even if you've just been to the toilet tummy pain a lump in your tummy bloating losing weight without trying feeling very tired or short of breath – these are signs of anaemia, which can be caused by bowel cancer Should anyone experience symptoms of bowel cancer for more than three weeks, it's imperative to consult a doctor. The NHS offers comfort, stating: "Try not to be embarrassed. The doctor or nurse will be used to talking about these symptoms." If you observe that your stools are black or dark red, or if you're suffering from bloody diarrhoea, it's essential to arrange an urgent GP appointment or seek help from NHS 111. Assistance can be accessed by dialling 111 or using the online service at Cancer manifests in over 200 different varieties and can impact any part of the body, including organs, blood, bone marrow, and the immune system. In some cases, cancer may spread from its original location to other areas of the body, a process referred to as secondary cancer or metastasis. The specific type of cancer dictates the treatment approach. Standard treatments for cancer include surgical removal of the tumour, chemotherapy with drugs designed to eradicate cancer cells, and radiotherapy which employs radiation to target and eliminate cancer cells. Additional treatment methods might encompass immunotherapy, enhancing the immune system's ability to combat cancer, and hormone therapy, aimed at decelerating or stopping the proliferation of cancerous cells. The NHS reassures patients: "You'll be looked after by a team of specialists who will work with you to create a treatment plan that is best for you."

More testing needed for genetic cancer risk as too many women ‘missed', experts say
More testing needed for genetic cancer risk as too many women ‘missed', experts say

The Independent

timean hour ago

  • The Independent

More testing needed for genetic cancer risk as too many women ‘missed', experts say

A new study has revealed that families of some cancer patients are being denied the opportunity to learn about their potential cancer risk due to inconsistencies in genetic testing. Academics have warned that the absence of adequate testing for Lynch syndrome is leaving some cancer patients unaware of their risk of developing other cancers. Lynch syndrome, a rare hereditary condition, elevates the risk of cancers of the bowel, womb, and ovaries. It arises from a gene mutation affecting DNA error correction during replication, potentially leading to uncontrolled cell growth. NHS guidelines stipulate that patients with bowel or womb cancer should undergo tumour assessments for Lynch syndrome markers. The identification of these markers should prompt a referral for genetic testing, confirming the diagnosis and enabling access to support and guidance regarding cancer risks for both the patients and their families. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. They found that 91 per cent of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64 per cent) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48 per cent of those eligible went on to get the test. Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected. 'Tumour testing is only cost-effective if it leads to diagnosis — we urgently need to make mainstream testing truly mainstream.'

Women with genetic cancer risk being ‘missed' due to testing gaps
Women with genetic cancer risk being ‘missed' due to testing gaps

Powys County Times

time2 hours ago

  • Powys County Times

Women with genetic cancer risk being ‘missed' due to testing gaps

Families of some cancer patients are being denied the chance to find out about their cancer risk due to gaps in genetic testing, a new study has suggested. A lack of testing for Lynch syndrome also means some cancer patients are unaware of their risk of developing other cancers, academics said. Lynch syndrome is a rare condition which runs in families which puts people at a higher risk of developing cancers of the bowel, womb and ovaries. It is caused by a mutation in the gene that fixes mistakes in DNA when it is copied, which can lead to uncontrolled cell growth. Patients with bowel or womb cancer should have their tumours assessed for markers of Lynch syndrome, according to guidance for the NHS. If these markers are identified, patients should be referred for genetic testing so the diagnosis can be confirmed and they can get support and advice about cancer risk for themselves and their family. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. We have launched a Guide to #LynchSyndrome to help provide information and support to anyone who thinks they may have it, that it may run in the family, or have found out they have it. — The Eve Appeal (@eveappeal) February 13, 2023 They found that 91% of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64%) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48% of those eligible went on to get the test. Today's #LynchSyndromeAwarenessDay. Our policy team sat down with our supporter, Jane, to share her experience. As well as highlighting what else needs to be done to improve Lynch syndrome care. Read our blog: — Bowel Cancer UK (@bowelcanceruk) March 22, 2025 Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store